Post by LSEG

Join us live for the upcoming Reuters NEXT Newsmaker with Genentech CEO Ashley Magargee. Reuters Global Pharma Editor Michele Gershberg sits down at Pharma USA 2026 in Philadelphia with Magargee. At the helm of Genentech for two years, the discussion will cover the sweeping shifts underway in US and global health policy, the growing influence of AI on drug discovery and regulatory pathways, and the next generation of promising treatments poised to reshape medical practice. Genentech is the US-based pioneering biotechnology company owned by Switzerland-based Roche and has been at the forefront of the development of complex biologic medicines used to treat conditions ranging from cancer to multiple sclerosis. Register now: https://lseg.group/3NsM7fw